Logo image of NCL

NORTHANN CORP (NCL) Stock Fundamental Analysis

USA - NYSEARCA:NCL - US66373M2008 - Common Stock

0.638 USD
-0.06 (-8.12%)
Last: 10/17/2025, 8:04:03 PM
0.63 USD
-0.01 (-1.25%)
After Hours: 10/17/2025, 8:04:03 PM
Fundamental Rating

1

NCL gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 41 industry peers in the Building Products industry. NCL has a bad profitability rating. Also its financial health evaluation is rather negative. NCL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

NCL had negative earnings in the past year.
In the past year NCL has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: NCL reported negative net income in multiple years.
In the past 5 years NCL reported 4 times negative operating cash flow.
NCL Yearly Net Income VS EBIT VS OCF VS FCFNCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -50.50%, NCL is doing worse than 95.12% of the companies in the same industry.
The Return On Equity of NCL (-190.30%) is worse than 92.68% of its industry peers.
Industry RankSector Rank
ROA -50.5%
ROE -190.3%
ROIC N/A
ROA(3y)-25.83%
ROA(5y)-14.23%
ROE(3y)-448.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCL Yearly ROA, ROE, ROICNCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

NCL has a worse Gross Margin (8.43%) than 95.12% of its industry peers.
NCL's Gross Margin has improved in the last couple of years.
NCL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.35%
GM growth 5YN/A
NCL Yearly Profit, Operating, Gross MarginsNCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 -40

More info and screens

3

2. Health

2.1 Basic Checks

NCL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NCL has more shares outstanding
Compared to 1 year ago, NCL has an improved debt to assets ratio.
NCL Yearly Shares OutstandingNCL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
NCL Yearly Total Debt VS Total AssetsNCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

NCL has an Altman-Z score of 4.41. This indicates that NCL is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NCL (4.41) is comparable to the rest of the industry.
NCL has a Debt/Equity ratio of 0.65. This is a neutral value indicating NCL is somewhat dependend on debt financing.
NCL has a Debt to Equity ratio (0.65) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z 4.41
ROIC/WACCN/A
WACC9.27%
NCL Yearly LT Debt VS Equity VS FCFNCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

NCL has a Current Ratio of 1.02. This is a normal value and indicates that NCL is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.02, NCL is not doing good in the industry: 87.80% of the companies in the same industry are doing better.
NCL has a Quick Ratio of 1.02. This is a bad value and indicates that NCL is not financially healthy enough and could expect problems in meeting its short term obligations.
NCL has a Quick ratio of 0.58. This is amonst the worse of the industry: NCL underperforms 92.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.58
NCL Yearly Current Assets VS Current LiabilitesNCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

NCL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 61.66%, which is quite impressive.
NCL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -20.88%.
Measured over the past years, NCL shows a very negative growth in Revenue. The Revenue has been decreasing by -23.68% on average per year.
EPS 1Y (TTM)61.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.52%
Revenue 1Y (TTM)-20.88%
Revenue growth 3Y-23.68%
Revenue growth 5YN/A
Sales Q2Q%-56.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCL Yearly Revenue VS EstimatesNCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NCL. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NCL Price Earnings VS Forward Price EarningsNCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCL Per share dataNCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NCL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NORTHANN CORP

NYSEARCA:NCL (10/17/2025, 8:04:03 PM)

After market: 0.63 -0.01 (-1.25%)

0.638

-0.06 (-8.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.64%
Inst Owner Change-0.01%
Ins Owners20.87%
Ins Owner Change0%
Market Cap13.99M
AnalystsN/A
Price TargetN/A
Short Float %0.83%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.32
P/FCF N/A
P/OCF N/A
P/B 25.56
P/tB 32.97
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.07
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.5%
ROE -190.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.43%
FCFM N/A
ROA(3y)-25.83%
ROA(5y)-14.23%
ROE(3y)-448.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.35%
GM growth 5YN/A
F-Score3
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.58
Altman-Z 4.41
F-Score3
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.88%
Revenue growth 3Y-23.68%
Revenue growth 5YN/A
Sales Q2Q%-56.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y9.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y73.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y73.64%
OCF growth 3YN/A
OCF growth 5YN/A